Characteristics, Comorbidities, and Outcomes of 18 – 35 Years Old COVID-19 Patients with Severe Symptoms at Dr. Soetomo Hospital Surabaya
Tazkia Izzatun Az Zahra1, Asra Al Fauzi2*, Gatot Soegiarto3
Abstract
Background: At the end of December 2019, a case of pneumonia with an unknown cause was found in Wuhan City, China, and spread rapidly throughout the world. Until March 2020, WHO defined this disease as Corona Virus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and declared this situation as a pandemic. This disease causes high mortality in patients who experience severe/critical symptoms. Several studies were conducted to conduct further research on the elderly which led to a lack of disease information in young adults who are thought to have a greater survival rate. In fact, young adult patients also have the potential to die from COVID-19. Therefore, this study was conducted to obtain a real picture of the clinical manifestations and outcomes of young adult COVID-19 patients so that it can be used by health policymakers to determine more appropriate prevention and management measures in this population. Methods: This study is an observational descriptive study with a retrospective study design using secondary data from medical records of COVID-19 patients at RSUD Dr. Soetomo, Surabaya. Results: In young adult patients, we identified the average age was 30,5 (SD±3,7). From 138 cases included in the inclusion criteria, there were 79,7% of patients discharged and 20,3% deaths. Our findings showed there are more women (56,5%) with 42.3% of them being pregnant than men. Examination of vital signs showed a decrease in oxygen saturation (80±0,19) and heart rate (109,93±24,61) in patients who died. Laboratory examination showed an increase in the number of white blood cells count (11,63±9,61), neutrophils (76,97±13,21), creatinine (1,26±2,98), SGOT (71,29±70,36), SGPT (88,75±103,83), and d-dimer (3.801,74±6.408,12) as well as a decrease in lymphocytes (15,19±9,42). The most comorbidities experienced by patients are obesity (29,7%), liver disease (21,7%), diabetes mellitus (15,9%), and hypertension (13,8%). Conclusion: From the results of the research conducted, we found a profile picture of the characteristics, comorbidities, and outcomes of COVID-19 patients in young adults at Dr. Soetomo Hospital, Surabaya for the period of April 2020 – September 2021.
Keywords
COVID-19; young adult; characteristic; comorbidities; outcomes; mortality
Cite This Article
Zahra, T. I. A., Fauzi, A. A., Soegiarto, G. (2024). Characteristics, Comorbidities, and Outcomes of 18 – 35 Years Old COVID-19 Patients with Severe Symptoms at Dr. Soetomo Hospital Surabaya. International Journal of Scientific Advances (IJSCIA), Volume 5| Issue 4: Jul-Aug 2024, Pages 780-788, URL: https://www.ijscia.com/wp-content/uploads/2024/08/Volume5-Issue4-Jul-Aug-No.648-780-788.pdf
Volume 5 | Issue 4: Jul-Aug 2024
